Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vicagrel Phase II in CAD Patients Undergoing PCI
NCT03599284Phase 2Completed
- Sponsor
- Jiangsu Vcare PharmaTech Co., Ltd.
- Start
- Aug 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vicagrel in coronary artery disease (CAD), sponsored by Jiangsu Vcare PharmaTech Co., Ltd.. Started Aug 2018; status: completed.
02
Drugs
vicagrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03599284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03599284.